Back to KROS
GOLDMAN SACHS GROUP INC → KROS
GOLDMAN SACHS GROUP INC KROS Position History
Keros Therapeutics, Inc. • Healthcare
Quarters held
16
Latest value
$1.2M
Q3 2026
Peak value
$13.6M
First seen
Q2 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q2 2025 | $5.6M |
| Q2 2025 | $6M |
| Q2 2025 | $162K |
| Q3 2025 | $13.6M |
| Q3 2025 | $7.1M |
| Q3 2025 | $191K |
| Q4 2025 | $6M |
| Q4 2025 | $6M |
| Q4 2025 | $6M |
| Q4 2025 | $6M |
| Q1 2026 | $1.3M |
| Q1 2026 | $1.2M |
| Q2 2026 | $942K |
| Q2 2026 | $961K |
| Q3 2026 | $1.7M |
| Q3 2026 | $1.2M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $1.2M | 102.8K | — | — |
| Q3 2026 | $1.7M | 151.3K | — | — |
| Q2 2026 | $961K | 89.8K | — | — |
| Q2 2026 | $942K | 88.1K | — | — |
| Q1 2026 | $1.2M | 108.3K | — | — |
| Q1 2026 | $1.3M | 116.1K | — | — |
| Q4 2025 | $6M | 295.9K | — | — |
| Q4 2025 | $6M | 294.6K | — | — |
| Q4 2025 | $6M | 294.6K | — | — |
| Q4 2025 | $6M | 295.9K | — | — |
| Q3 2025 | $191K | 12.1K | — | — |
| Q3 2025 | $7.1M | 450.7K | — | — |
| Q3 2025 | $13.6M | 862.7K | — | — |
| Q2 2025 | $162K | 12.1K | — | — |
| Q2 2025 | $6M | 450.1K | — | — |
| Q2 2025 | $5.6M | 421.3K | — | — |